Related Experiment Video
Updated: Aug 29, 2026

Differentiating Functional Roles of Gene Expression from Immune and Non-immune Cells in Mouse Colitis by Bone Marrow Transplantation
Published on: October 1, 2012
Ischemic colitis as a manifestation of thrombotic microangiopathy following bone marrow transplantation
Yukiko Komeno1, Seishi Ogawa, Tateru Ishida
1Department of Cell Therapy & Transplantation Medicine, University of Tokyo Hospital, Tokyo.
Abstract:
Thrombotic microangiopathy (TMA) is a microvascular disorder characterized by platelet aggregation and hemolytic anemia. In the setting of bone marrow transplantation (BMT), ischemic colitis due to TMA is difficult to differentiate from acute graft-versus-host disease. We report a 32-year-old man who presented ischemic colitis due to TMA after unrelated BMT for myelodysplastic syndrome. He suffered from treatment-resistant bloody diarrhea, and died of renal failure and Aspergillus pleuritis on day 253 post-BMT. Autopsy revealed endothelial injuries of arterioles and ischemic changes in the intestines and kidneys. Clinical and pathological characteristics of ischemic colitis due to BMT-associated TMA are described.
Insights
Thrombotic microangiopathy (TMA) after bone marrow transplantation (BMT) can cause ischemic colitis, mimicking graft-versus-host disease. This case highlights TMA
Area of Science:
- Hematology
- Transplantation Medicine
- Gastroenterology
Background:
- Thrombotic microangiopathy (TMA) is a serious vascular complication.
- Differentiating TMA-induced ischemic colitis from graft-versus-host disease post-bone marrow transplantation (BMT) is clinically challenging.
- Myelodysplastic syndrome is a common indication for BMT.
Observation:
- A 32-year-old male developed ischemic colitis following unrelated BMT for myelodysplastic syndrome.
- The patient experienced severe, treatment-resistant bloody diarrhea.
- Post-BMT complications included renal failure and Aspergillus pleuritis, leading to death.
Findings:
- Autopsy confirmed endothelial injury in arterioles and ischemic changes in the intestines and kidneys.
- The clinical presentation and pathological findings were consistent with BMT-associated TMA.
- This case underscores the diagnostic difficulty in distinguishing TMA from acute graft-versus-host disease.
Implications:
- Recognizing TMA as a cause of ischemic colitis post-BMT is crucial for timely diagnosis and management.
- Understanding the pathological features of BMT-associated TMA can improve patient outcomes.
- Further research into differentiating TMA from graft-versus-host disease is warranted.
Related Concept Videos
Inflammatory Bowel Disease IV: Clinical Manifestations
Inflammatory Bowel Disease II: Ulcerative Colitis
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory Bowel Disease III: Crohn's Disease
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...

